EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 0.1734
March 31, 2026 -0.0482
December 31, 2025 -0.0758
September 30, 2025 -0.0889
June 30, 2025 0.4946
March 31, 2025 -0.0057
December 31, 2024 0.6409
September 30, 2024 0.0187
June 30, 2024 0.0255
March 31, 2024 0.1436
December 31, 2023 1.016
September 30, 2023 -0.0055
June 30, 2023 -0.0404
March 31, 2023 -0.0127
December 31, 2022 -0.0112
September 30, 2022 0.451
June 30, 2022 0.0271
March 31, 2022 -0.0096
December 31, 2021 0.9716
September 30, 2021 -0.0416
June 30, 2021 -0.0034
March 31, 2021 -0.0106
December 31, 2020 0.2579
September 30, 2020 0.3094
June 30, 2020 0.2594
Date Value
March 31, 2020 -0.1095
December 31, 2019 -0.0554
September 30, 2019 -0.0266
June 30, 2019 -0.0465
March 31, 2019 -0.0183
December 31, 2018 0.65
September 30, 2018 4.707
June 30, 2018 -0.0891
March 31, 2018 -0.1465
December 31, 2017 -0.13
September 30, 2017 -0.12
June 30, 2017 -0.0952
March 31, 2017 -0.1094
December 31, 2016 -0.15
September 30, 2016 -0.17
June 30, 2016 -0.18
March 31, 2016 -0.19
December 31, 2015 -0.3713
September 30, 2015 -0.10
June 30, 2015 -0.12
March 31, 2015 -0.13
December 31, 2014 -0.36
September 30, 2014 -4.49
June 30, 2014 -0.06
March 31, 2014 -0.06

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 1.052
Corcept Therapeutics, Inc. 0.356
Veru, Inc. -0.3032
Johnson & Johnson 0.0858
Eli Lilly & Co. 7.939